Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Veterinary Cardiology Market Size Outlook: How Quickly Will Revenue Expand Through 2030?#_x000D_
The veterinary cardiology market has demonstrated substantial growth in recent years. Its value is projected to expand from $3.1 billion in 2025 to $3.38 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be attributed to several factors including a higher incidence of congenital heart defects in companion animals, increased understanding of pet health requirements, an expanding presence of veterinary hospitals and clinics, innovations in diagnostic imaging techniques, and the adoption of conventional pharmaceuticals for treating cardiac conditions._x000D_
_x000D_
The veterinary cardiology market size is expected to experience significant growth in the coming years. It is projected to expand to $4.73 billion by 2030, showing a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is attributed to the growing acceptance of telemedicine in veterinary cardiology, increased pet insurance penetration, the creation of AI-driven diagnostic instruments, a heightened focus on proactive and individualized cardiac care, and the rising number of companion animals in urban areas. Significant developments anticipated during this period include telecardiology and remote heart monitoring, less invasive cardiac interventions, custom treatment approaches for companion animals, sophisticated cardiac imaging methods, and the use of nutraceuticals for preventative heart health._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Veterinary Cardiology Market Demand Drivers Opening New Revenue Streams#_x000D_
The increasing instances of heart conditions in pets and livestock are anticipated to stimulate the expansion of the veterinary cardiology market in the future. These conditions involve medical issues that impact the heart’s structure and performance, leading to impaired blood circulation, reduced cardiac efficiency, and potential wider health complications. The surge in heart diseases among pets and livestock is influenced by elements such as longer lifespans, obesity, inadequate nutrition, genetic predispositions, and a lack of consistent veterinary attention. Additionally, environmental pressures and changes in living environments can contribute to the prevalence of cardiovascular issues in these animals. Veterinary cardiology offers diagnosis, treatment, and management for heart diseases in pets and livestock through specialized care, advanced imaging, and innovative procedures like minimally invasive surgeries, aiming to improve cardiac health and quality of life. For instance, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, Myxomatous mitral valve degeneration (MMVD) stands as the most common heart disease in dogs in North America, representing 75% of all canine cardiac conditions. It is documented that 85% of small dogs aged 13 years show indicators of a myxomatous mitral valve lesion, although the mere presence of a lesion does not always signify clinical importance. In cases involving MMVD, the estimated rate of cardiac-related deaths in dogs falls between 40% and 70%. Therefore, the growing number of heart disease cases in pets and livestock will propel the growth of the veterinary cardiology market._x000D_
_x000D_
#Veterinary Cardiology Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_
The veterinary cardiology market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Pharmaceuticals, Diagnostics_x000D_
2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications_x000D_
3) By Animal Type: Companion Animals, Production Animals_x000D_
4) By End-User: Veterinary Hospitals, Clinics, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health _x000D_
2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring _x000D_
_x000D_
#Veterinary Cardiology Market Trends Powering Strategic Industry Growth#_x000D_
Major companies in the veterinary cardiology market are developing technological advancements, including transcatheter edge-to-edge mitral valve repair (TEER), to improve the treatment of heart conditions in animals, enhance surgical results, and provide minimally invasive alternatives for better patient recuperation and quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less intrusive heart procedure aimed at correcting mitral valve leakage by employing a clamp to improve valve function and reduce strain on the heart. For example, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral facility, introduced an innovative heart treatment for dogs to manage myxomatous mitral valve disease (MMVD), which is the most prevalent heart ailment in dogs. This treatment is now considered a viable alternative to surgical repair in human patients, with early clinical outcomes in dogs demonstrating significant potential. The procedure is performed under general anesthesia via a minor incision in the chest wall. A needle is inserted at the heart’s apex, guided precisely by continuous X-rays and transesophageal ultrasound. This method facilitates the accurate positioning of a V-clamp across the mitral valve to minimize leakage._x000D_
_x000D_
#Veterinary Cardiology Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet _x000D_
_x000D_
#View The Full Veterinary Cardiology Market Report:#_x000D_
_x000D_
#Veterinary Cardiology Market Regional Breakdown: Where Is Demand Concentrated?#_x000D_
North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
